Soyong Eom1, Ha Neul Lee2, Sunho Lee2, Hoon-Chul Kang3, Joon Soo Lee3, Heung Dong Kim3, Young-Mock Lee4. 1. Epilepsy Research Institute, Yonsei University College of Medicine, Seoul, Korea. 2. Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. 3. Division of Pediatric Neurology, Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea. 4. Department of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Electronic address: ymleemd@yuhs.ac.
Abstract
BACKGROUND: We investigated the clinical characteristics that represent risk factors for death in pediatric patients with mitochondrial diseases. METHODS: The medical records of mitochondrial disease pediatric patients attended between 2006 and 2015 (n = 221) were reviewed for clinical characteristics, diagnosis, hospitalization, follow-up, survival, and cause of death. RESULTS: The global mortality rate in the cohort was 14% (average age at death, six years). By syndromic diagnosis, the mortality rates were as follows: Leigh syndrome, 17% (15 of 88); mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, 50% (two of four); and nonspecific mitochondrial disease, 11% (14 of 129). Data regarding 31 patients (17 males) were included in the analysis of cause of death. The age at symptom onset, lead time to diagnosis, duration of illness, and duration of life were 1.8 ± 2.0, 1.7 ± 1.5, 4.3 ± 2.7, and 6.1 ± 2.9 years, respectively. The most common causes of death were sepsis, pneumonia, disseminated intravascular coagulation, and sudden unexpected death (55%, 42%, 29%, and 29%, respectively). Early death (age six years or younger) was associated with lesions in the thalamus, number of organs involved, and Leigh syndrome. CONCLUSIONS: Careful monitoring of the medical condition and early intervention are key to improving survival in pediatric patients with mitochondrial disease.
BACKGROUND: We investigated the clinical characteristics that represent risk factors for death in pediatric patients with mitochondrial diseases. METHODS: The medical records of mitochondrial disease pediatric patients attended between 2006 and 2015 (n = 221) were reviewed for clinical characteristics, diagnosis, hospitalization, follow-up, survival, and cause of death. RESULTS: The global mortality rate in the cohort was 14% (average age at death, six years). By syndromic diagnosis, the mortality rates were as follows: Leigh syndrome, 17% (15 of 88); mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, 50% (two of four); and nonspecific mitochondrial disease, 11% (14 of 129). Data regarding 31 patients (17 males) were included in the analysis of cause of death. The age at symptom onset, lead time to diagnosis, duration of illness, and duration of life were 1.8 ± 2.0, 1.7 ± 1.5, 4.3 ± 2.7, and 6.1 ± 2.9 years, respectively. The most common causes of death were sepsis, pneumonia, disseminated intravascular coagulation, and sudden unexpected death (55%, 42%, 29%, and 29%, respectively). Early death (age six years or younger) was associated with lesions in the thalamus, number of organs involved, and Leigh syndrome. CONCLUSIONS: Careful monitoring of the medical condition and early intervention are key to improving survival in pediatric patients with mitochondrial disease.
Authors: Shannon K Kruk; Susan E Pacheco; Mary Kay Koenig; Jenna R E Bergerson; Eliza Gordon-Lipkin; Peter J McGuire Journal: J Allergy Clin Immunol Pract Date: 2019-04-05
Authors: T Abruzzo; R van den Berg; S Vadivelu; S W Hetts; M Dishop; P Cornejo; V Narayanan; K E Ramsey; C Coopwood; E G Medici-van den Herik; S D Roosendaal; M Lawton; S Bernes Journal: AJNR Am J Neuroradiol Date: 2022-06-30 Impact factor: 4.966
Authors: Mandy H Y Tsang; Anna K Y Kwong; Kate L S Chan; Jasmine L F Fung; Mullin H C Yu; Christopher C Y Mak; Kit-San Yeung; Richard J T Rodenburg; Jan A M Smeitink; Rachel Chan; Thomas Tsoi; Joannie Hui; Shelia S N Wong; Shuk-Mui Tai; Victor C M Chan; Che-Kwan Ma; Sharon T H Fung; Shun-Ping Wu; W K Chak; Brian H Y Chung; Cheuk-Wing Fung Journal: Hum Genomics Date: 2020-09-10 Impact factor: 4.639
Authors: Grigorij Schleifer; Eizo Marutani; Michele Ferrari; Rohit Sharma; Owen Skinner; Olga Goldberger; Robert Matthew Henry Grange; Kathryn Peneyra; Rajeev Malhotra; Martin Wepler; Fumito Ichinose; Donald B Bloch; Vamsi K Mootha; Warren M Zapol Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-12-06 Impact factor: 5.464
Authors: Yuanjiu Lei; Camila Guerra Martinez; Sylvia Torres-Odio; Samantha L Bell; Christine E Birdwell; Joshua D Bryant; Carl W Tong; Robert O Watson; Laura Ciaccia West; A Phillip West Journal: Sci Adv Date: 2021-05-26 Impact factor: 14.136